https://www.selleckchem.com/pr....oducts/wnt-agonist-1
8 vs. 0.8%; p=0.0004) as well as for the p.T790M resistance mutation (median MAFs=8.69 vs. 0.16%; p=0.039. Importantly, two patients who had progressed on first-generation -tyrosine kinase inhibitors with a dubious result for p.T790M plasma (MAFs=0.11%) had an indisputably positive result in their respective body fluid samples (MAFs=10.25 and 9.66%). ctDNA derived from body fluids is an informative source for biomarker testing, with greater sensitivity than plasma samples. ctDNA derived from body fluids is an informative source
Мне нравится
Комментарий
Перепост
